VPM1002Immuvacextrapulmonary TB
…gainst extrapulmonary TB in participants aged 6-14 years in the VPM1002 group.Conclusions Both vaccines were safe but did not show any …
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Immuvac ×
Immuvac
This drug is selected. Its supporting articles are shown below.